Sign in

CIK 0000730272

  • Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
042729386
Phone
+1 781-449-9560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,953,260
in 5 filings, $6.0M under 10b5-1 plans

Net −$5,953,260. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Loeillot Olivier −$6.0M Chief Executive Officer sold 41% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-02-27 Garland Jason K CFO Grant or award +2,540 8,043
2024-02-27 Garland Jason K CFO Grant or award · Stock Option (Right to Buy) +2,523 2,523
2024-02-27 Loeillot Olivier President and CCO Grant or award +2,880 15,786
2024-02-27 Loeillot Olivier President and CCO Grant or award · Stock Option (Right to Buy) +2,860 2,860
2024-02-27 DAWES KAREN A Director Option exercise +4,626 $42.07 $195K 88,367
2024-02-27 DAWES KAREN A Director Sale −1,000 $193.35 $193K 87,367
2024-02-27 DAWES KAREN A Director Option exercise · Stock Option (Right to Buy) +4,626 0
2024-02-23 Bylund James Chief Operating Officer Option exercise +940 $94.33 $89K 18,508
2024-02-23 Bylund James Chief Operating Officer Sale −4,373 $198.08 $866K 14,135
2024-02-23 Bylund James Chief Operating Officer Option exercise · Stock Option (Right to Buy) +940 4,000
2023-11-14 Hunt Anthony Chief Executive Officer Gift −1,000 194,307
2023-11-10 Gebski Christine See Remarks Sale −3,788 $147.13 $557K 28,787
2023-10-02 Loeillot Olivier President and CCO Grant or award +12,906 12,906
2023-10-02 Loeillot Olivier President and CCO Grant or award · Stock Option (Right to Buy) +24,236 24,236
2023-09-25 Garland Jason K CFO Grant or award +5,503 5,503
2023-09-25 Garland Jason K CFO Grant or award · Stock Option (Right to Buy) +10,524 10,524
2023-08-29 DAWES KAREN A Director Option exercise +7,392 $18.12 $134K 84,591
2023-08-29 DAWES KAREN A Director Sale −850 $171.38 $146K 83,741
2023-08-29 DAWES KAREN A Director Option exercise · Stock Option (Right to Buy) +7,392 0
2023-05-18 Madaus Martin D Director Grant or award +686 2,297

Page 14 of 23 · 455 trades